DekaBank Deutsche Girozentrale’s Tango Therapeutics TNGX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-60,000	Closed	-$502K	–	1346
2025 Q4	$502K	Hold	60,000	–	–	﹤0.01%	997
2025 Q3	$497K	Hold	60,000	–	–	﹤0.01%	990
2025 Q2	$502K	Hold	60,000	–	–	﹤0.01%	985
2025 Q1	$463K	Hold	60,000	–	–	﹤0.01%	989
2024 Q4	$438K	Hold	60,000	–	–	﹤0.01%	1027
2024 Q3	$462K	Hold	60,000	–	–	﹤0.01%	1030
2024 Q2	$462K	Hold	60,000	–	–	﹤0.01%	1022
2024 Q1	$462K	Hold	60,000	–	–	﹤0.01%	1014
2023 Q4	$621K	Hold	60,000	–	–	﹤0.01%	996
2023 Q3	$653K	Buy	+60,000	New	+$366K	﹤0.01%	958

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TNGX Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 60,000 shares — an estimated $502K sold.

DekaBank Deutsche Girozentrale first reported a position in TNGX in Q3 2023 and held it in 10 quarters. The position peaked at $653K in Q3 2023. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 60,000 Tango Therapeutics shares in Q1 2026, an estimated $502K.
DekaBank Deutsche Girozentrale first reported a position in Tango Therapeutics in Q3 2023 and held it in 10 quarters.
DekaBank Deutsche Girozentrale's Tango Therapeutics position peaked at $653K in Q3 2023.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.